Jessica S. Donington, Professor and Chief Thoracic Surgery University of Chicago, shared a post by Elliot Servais, on X:
“I said that and believe that.
N2 + lung cancer can and should be surgical disease if R0 is possible!”
Elliot Servais, thoracic surgeon in Burlington, Massachusetts.
“100%
When patients can be resected with R0 and periop chemo-ICI (including N2 single or multi-station) as in Checkmate 77T, 76% 2-year EFS in locoregionally advanced NSCLC.
These results are unmatched to date for resectable N2. (Resectable defined by ability to achieve R0).”
Source: Jessica Donington/X and Elliot Servais/X